SCHEMBL4877872

SCHEMBL4877872

COc1ccc(Cc2nc(NC(=O)O)sc2Br)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.48
MAPT P10636 3/20 0.48
ALDH1A1 P00352 2/20 0.48
GSK3A P49840 1/20 0.46
GSK3B P49841 1/20 0.46
NPC1 O15118 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PTGDR2 Q9Y5Y4 2/20 0.46
GAA P10253 1/20 0.46
ALOX12 P18054 1/20 0.46
TP53 P04637 1/20 0.46
SAE1 Q9UBE0 1/20 0.45
UBA2 Q9UBT2 1/20 0.45
CSNK1D P48730 1/20 0.45
KDM4E B2RXH2 2/20 0.44
RAB9A P51151 2/20 0.44
TSHR P16473 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4876702 0.85 MAPT (0.49) LMNAMAPTALDH1A1GSK3AGSK3B
SCHEMBL1743735 0.76 ALDH1A1 (0.39) MAPTALDH1A1NPC1SMN1; SMN2GAA
SCHEMBL370888 0.75 L3MBTL1 (0.46) LMNAMAPTALDH1A1GSK3AGSK3B
SCHEMBL5520026 0.72 ALOX5 (0.47) LMNAMAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL14108630 0.72 LMNA (0.53) LMNAMAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL2690687 0.71 PTPN11 (0.55) LMNAMAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL1930792 0.71 GAA (0.46) LMNAMAPTALDH1A1GSK3AGSK3B
SCHEMBL4397796 0.70 SCD (0.44) MAPTALDH1A1NPC1SMN1; SMN2GAA
SCHEMBL29135461 0.70 SAE1 (0.78) LMNAMAPTALDH1A1NPC1SMN1; SMN2
SCHEMBL9555500 0.70 PTGDR2 (0.67) ALDH1A1PTGDR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080076771-A1 Thrombopoietin Receptor Agonists REITER LAWRENCE A 2008-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076771-A1 Thrombopoietin Receptor Agonists MPL, THPO, TBXA2R LMNA 2506/4885MAPT 4880/4885ALDH1A1 2423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.